All Stories

  1. Comment on: “Population Pharmacokinetics of Intravenous Vitamin C in Adults with Sepsis: A Sub-Study of the LOVIT Trial”
  2. Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury
  3. Kansallinen koe kirjoittamisen, kirjoittamisen ja laskemisen testaamiseksi. Vastine lyhyempään kirjoitukseen: Laura Ketonen ja Päivi Atjonen (Kasvatus 2/2025)
  4. Vitamin C and cardiovascular disease
  5. The UK’s vitamin C recommendations are not evidence-based
  6. Common cold treatments: a new method for analyzing their effects
  7. Vitamin C in infectious diseases: Misrepresentation of the evidence
  8. Cochrane review on zinc for the common cold (2024) misleads readers
  9. Errors in a Meta-analysis on Vitamin C and COVID-19
  10. Vitamin C for the common cold and pneumonia
  11. Cochrane review on zinc for the common cold (2024) misled readers
  12. Vitamin C for patients with sepsis?
  13. Evidence-based treatment of the common cold with zinc lozenges
  14. Rebound effect explains the divergence in survival after 5 days in a controlled trial on vitamin C for COVID-19 patients
  15. Response: Commentary: Quantile treatment effect of zinc lozenges on common cold duration: a novel approach to analyze the effect of treatment on illness duration
  16. Scurvy can cause pulmonary hypertension
  17. Vitamin C reduces the severity of colds
  18. Concerns with the revised Japanese recommendation for administering vitamin C to septic patients
  19. Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis
  20. Zinc and Coronavirus Disease 2019
  21. Vitamin C: abrupt termination may increase mortality of sepsis patients
  22. Pitfalls in choosing data examples for methodological work: Bayesian approaches to a fixed effects meta‐analysis of zinc lozenges for the common cold
  23. Vitamin C and the risk of atrial fibrillation: Mendelian randomization study may be misleading
  24. Vitamin C and the risk of cardiovascular diseases: Mendelian randomization study may be misleading
  25. Vitamin C may improve the mechanical efficiency of the heart
  26. Mendelian randomization can lead to flawed conclusions about the effects of vitamin C
  27. Quantile treatment effect of zinc lozenges on common cold duration: a novel approach
  28. Bias against vitamin C has hampered the recognition of positive findings from randomized trials
  29. Vitamin C and zinc lozenges for COVID-19?
  30. Carrageenan nasal spray can shorten the common cold and the effect is greater on longer colds
  31. Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial
  32. Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19
  33. Vitamin C may increase the recovery rate of outpatient cases of SARS-CoV-2 infection by 70%: reanalysis of the COVID A to Z Randomized Clinical Trial
  34. Commentary: Vitamin C supplementation for prevention and treatment of pneumonia
  35. Vitamin C and COVID-19
  36. Benefit of OTC Formula Against COVID-19 Is Explained by Selection Bias
  37. Comment on “Therapeutic target and molecular mechanism of vitamin C-treated pneumonia: a systematic study of network pharmacology” by R. Li, C. Guo, Y. Li, X. Liang, L. Yang and W. Huang, Food Funct., 2020, 11, 4765
  38. Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: re-analysis of randomized trial data
  39. Reanalysis of the Effect of Vitamin C on Mortality in the CITRIS-ALI Trial: Important Findings Dismissed in the Trial Report
  40. Cochrane has not consistently followed the COPE guidelines
  41. The current vitamin E recommendation in the USA is not supported by new empirical evidence
  42. Vitamin C for Cardiac Surgery Patients: Several Errors in a Published Meta-Analysis. Comment on “Effects of Vitamin C on Organ Function in Cardiac Surgery Patients: A Systematic Review and Meta-Analysis. Nutrients 2019, 11, 2103”
  43. Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis
  44. Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial
  45. The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
  46. Vitamin C as a Possible Therapy for COVID-19
  47. Many continuous variables should be analyzed using the relative scale: a case study of β2-agonists for preventing exercise-induced bronchoconstriction
  48. Zinc for preventing and treating the common cold
  49. Meta-analysis on vitamin C and the common cold in children may be misleading
  50. Random-Effects Assumption in Meta-analyses
  51. Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis
  52. Errors in a meta-analysis on vitamin C and post-operative atrial fibrillation
  53. Effect of β-Carotene Supplementation on the Risk of Pneumonia Is Heterogeneous in Males: Effect Modification by Cigarette Smoking
  54. Letter: Comparison of different vitamin E forms is confounded by heterogeneity in vitamin E effects
  55. Vitamin C in Clinical Therapeutics
  56. Zinc for preventing and treating the common cold
  57. Erroneus calculation of sample size in a vitamin C and atrial fibrillation trial
  58. Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale: a case study of two zinc lozenge trials
  59. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage
  60. Vitamins E and C May Differ in Their Effect on Contrast-Induced Acute Kidney Injury
  61. Vitamin E May Protect Against Contrast-Induced Acute Kidney Injury
  62. Vitamin C and Infections
  63. Publication bias in meta-analysis of ascorbic acid for postoperative atrial fibrillation
  64. Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis
  65. Zinc lozenges may triple the recovery rate of common cold patients
  66. Vitamin E and the risk of pneumonia: using the I 2 statistic to quantify heterogeneity within a controlled trial
  67. Many continuous variables such as the duration of the common cold should be analyzed using the relative scale
  68. Vitamin E administration may decrease the incidence of pneumonia in elderly males
  69. Zinc acetate lozenges may shorten common cold duration by 3 days
  70. Vitamin C for treating atrial fibrillation
  71. Thomas Chalmers, vitamin C and the common cold
  72. Zinc lozenges and vitamin C for the common cold are not examples of placebo effect in action
  73. Common Cold Treatment Using Zinc
  74. Impure placebo is a useless concept
  75. Exercise, Antioxidants, and the Risk for Pneumonia
  76. Zinc acetate lozenges may shorten common cold-associated nasal discharge by 34% and cough by 46%
  77. Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent Swimmers: A Randomized Controlled Trial
  78. Vitamin C for treating atrial fibrillation
  79. The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis
  80. Vitamin C and asthma
  81. Clinical use of placebo treatments may undermine the trust of patients: a response to Gold and Lichtenberg
  82. Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer
  83. Can CAM treatments be evidence‐based?
  84. Does Exercise Prevent the Common Cold?
  85. The Effect of Vitamin E on Mortality Is Not Uniform across the Population
  86. Vitamin C Should Be Tested against Exercise-induced Bronchoconstriction
  87. Vitamin C and common cold-induced asthma: a systematic review and statistical analysis
  88. Vitamin C for preventing and treating tetanus
  89. Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm?
  90. Vitamin C for preventing and treating pneumonia
  91. Vitamin supplements and mortality in older people
  92. Vitamin C may alleviate exercise-induced bronchoconstriction: a meta-analysis
  93. Placebo Use in the United Kingdom: Results from a National Survey of Primary Care Practitioners
  94. Vitamin C for preventing and treating the common cold
  95. Zinc lozenges may shorten common cold duration
  96. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials
  97. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
  98. Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density
  99. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
  100. Erratum to: Vitamin C and asthma in children: modification of the effect by age, exposure to dampness and the severity of asthma
  101. Vitamin C and Community-acquired Pneumonia
  102. Zinc Lozenges Shorten Colds
  103. The Effect of Vitamin C on the Common Cold
  104. Zinc for the common cold
  105. Subgroup analysis of large trials can guide further research: a case study of vitamin E and pneumonia
  106. Vitamin E may affect the life expectancy of men, depending on dietary vitamin C intake and smoking
  107. Vitamin C and asthma in children: modification of the effect by age, exposure to dampness and the severity of asthma
  108. Rabies, Still Neglected after 125 Years of Vaccination
  109. Randomised trials on vitamin C
  110. The effect of β-carotene on common cold incidence is modified by age and smoking: evidence against a uniform effect in a nutrient–disease relationship
  111. The effect of vitamin C on upper respiratory infections in adolescent swimmers: a randomized trial
  112. There is no alternative medicine
  113. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
  114. Vitamin C and the treatment of tetanus
  115. Vitamin C for the common cold should not be rejected on the basis of old and erroneous articles
  116. Vitamin D Level, Respiratory Tract Infections, and Controlled Trials
  117. Vitamin E is likely to affect mortality even at low doses
  118. Predicting the incidence of human campylobacteriosis in Finland with time series analysis
  119. Modification of the Effect of Vitamin E Supplementation on the Mortality of Male Smokers by Age and Dietary Vitamin C
  120. Letter to the Editor
  121. Vitamin C supplementation for asthma
  122. Vitamins and minerals
  123. Vitamin C and exercise-induced bronchoconstriction in athletes
  124. Evidence-based medicine and the role of antioxidants in physically stressed people
  125. Vitamin E supplementation and pneumonia risk in males who initiated smoking at an early age: effect modification by body weight and dietary vitamin C
  126. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake
  127. Cochrane review: Vitamin C for preventing and treating the common cold
  128. Commentaries on ‘Vitamin C for preventing and treating the common cold’ with responses from the review author
  129. Assessment of the importance of double‐blinding should be based on systematic reviews: a rebuttal
  130. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake – reply by Hemilä & Kaprio
  131. Vitamin C for preventing and treating tetanus
  132. Vitamin C and sex differences in respiratory tract infections
  133. THE AUTHOR REPLIES
  134. Exercise, Vitamins and Respiratory Tract Infections
  135. Vitamin C may affect lung infections
  136. Vitamin C may affect lung infections
  137. Antioxidant Supplements and Mortality
  138. VITAMIN E SUPPLEMENTATION AND RESPIRATORY INFECTIONS IN OLDER PEOPLE
  139. Vitamin C for preventing and treating tetanus
  140. Vitamin C for preventing and treating the common cold
  141. Evidence-based medicine and vitamin E supplementation
  142. Vitamin C and exercise-induced immunodepression
  143. RE: "BIAS IN CLINICAL INTERVENTION RESEARCH"
  144. Conclusions about intervention effects should not be based on surrogate end points
  145. Vitamin C for preventing and treating pneumonia
  146. Small trials focusing on surrogate end points may be uninformative
  147. Letter to the Editor
  148. The Effect of Vitamin E on Common Cold Incidence Is Modified by Age, Smoking and Residential Neighborhood
  149. Physical Activity and the Risk of Pneumonia in Male Smokers Administered Vitamin E and β-Carotene
  150. Analysis of clinical data with breached blindness by Shein-Chung Chow and Jun Shao,Statistics in Medicine 2004;23:1185–1193
  151. The Protective Effect of Vitamins A and C on Endotoxin-Induced Oxidative Renal Tissue Damage in Rats
  152. Potential harm of vitamin E supplementation
  153. Vitamin C for preventing and treating pneumonia
  154. Authors' Reply
  155. Misleading Information on the Properties of Vitamin C
  156. Echinacea, Vitamin C, the Common Cold, and Blinding
  157. Assessment of blinding may be inappropriate after the trial
  158. Allocation concealment and blinding: when ignorance is bliss
  159. High-Dosage Vitamin E Supplementation and All-Cause Mortality
  160. High-Dosage Vitamin E Supplementation and All-Cause Mortality
  161. Vitamin C for Preventing and Treating the Common Cold
  162. Vitamin E and Respiratory Tract Infections in Elderly Persons
  163. Vitamin C Supplementation and Respiratory Infections: a Systematic Review
  164. Vitamin C for preventing and treating the common cold
  165. Vitamin E and Beta-Carotene Supplementation and Hospital-Treated Pneumonia Incidence in Male Smokers
  166. Vitamin C and SARS coronavirus
  167. Vitamin C, respiratory infections and the immune system
  168. Physical Activity and the Common Cold in Men Administered Vitamin E and ??-Carotene
  169. Vitamin C, Vitamin E, and Beta-Carotene in Relation to Common Cold Incidence in Male Smokers
  170. Vitamin C and Other Compounds in Vitamin C Rich Food in Relation to Risk of Tuberculosis in Male Smokers
  171. Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit
  172. Vitamin C and Infectious Diseases
  173. Nutrition Discussion Forum
  174. Vitamin C intake and susceptibility to pneumonia
  175. Blood donation, body iron stores, and risk of myocardial infarction
  176. Vitamin C intake and susceptibility to the common cold
  177. Vitamin C supplementation and common cold symptoms: Problems with inaccurate reviews
  178. To the dissent by Thomas Chalmers
  179. Vitamin C, the placebo effect, and the common cold: A case study of how preconceptions influence the analysis of results
  180. Vitamin C and Common Cold Incidence: A Review of Studies with Subjects Under Heavy Physical Stress
  181. Vitamin C and the common cold: a retrospective analysis of Chalmers' review.
  182. THE GOOD AND HARM OF VITAMIN C
  183. Does Vitamin C Alleviate the Symptoms of the Common Cold? - A Review of Current Evidence
  184. Hormone-sensitive lipase is closely related to several bacterial proteins, and distantly related to acetylcholinesterase and lipoprotein lipase: Identification of a superfamily of esterases and lipases
  185. Cloning and sequencing of a gene encoding acidophilic amylase from Bacillus acidocaldarius
  186. Vitamin C, cholesterol, and the nutritional recommendations
  187. Improving the production of E. coli β-lactamase in Bacillus subtilis: the effect of glucose, pH and temperature on the production level
  188. Sequence encoding ribosomal protein L33 of Lactococcus lactis
  189. VITAMIN C, NEUTROPHILS AND THE SYMPTOMS OF THE COMMON COLD
  190. Expression of the Erwinia carotovora polygalacturonase-encoding gene in Bacillus subtilis: role of signal peptide fusions on production of a heterologous protein
  191. Vitamin C and the common cold
  192. Vitamin C and plasma cholesterol
  193. Lipoamide dehydrogenase of Staphylococcus aureus: nucleotide sequence and sequence analysis
  194. Vitamin C and lowering of blood pressure: need for intervention trials?
  195. Nucleotide sequence of a Lactococcus lactis gene cluster encoding adenylate kinase, initiation factor 1 and ribosomal proteins
  196. Production of heterologous proteins in Bacillus subtilis: the effect of the joint between signal sequence and mature protein on yield
  197. Nucleotide sequence of the secY gene from Lactococcus lactis and identification of conserved regions by comparison of four SecY proteins
  198. Sequence of a PAL-related lipoprotein fromBacillus subtilis
  199. Sequence of a PAL-related lipoprotein from Bacillus subtilis
  200. Production of pectin methylesterase from Erwinia chrysanthemi B374 in Bacillus subtilis
  201. Is there a biochemical basis for ‘nutrient need’?
  202. The secretory S complex in Bacillus subtilis is identified as pyruvate dehydrogenase
  203. Secretory S complex of Bacillus subtilis: sequence analysis and identity to pyruvate dehydrogenase.
  204. Production of diphtheria toxin CRM228 in B. subtilis
  205. Production of diphtheria toxin CRM228 inB. subtilis
  206. A re-evaluation of nutritional goals -not just deficiency counts
  207. Retinoids Activate Superoxide Production by Polymorphonuclear Leucocytes
  208. Activated polymorphonuclear leucocytes consume vitamin C
  209. Nutritional need versus optimal intake